Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of an increase in interests in Ordinary share ADRs of GlaxoSmithKline plc purchased at a price of $46.165 per ADR on 5 January 2012, in respect of the personal holdings of the under-mentioned persons following the re-investment of the dividend paid to shareholders on 5 January 2012.
Director/PDMR
|
Number of ADR's |
Connected Person |
Number of ADR's |
Dr M M Slaoui
|
412.646 |
Dr K Slaoui |
8.790 |
Mr W C Louv |
179.889 |
- |
- |
Dr D Pulman
|
259.197 |
- |
- |
The Company was advised of this information on 12 January 2012.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rules 3.1.4R(1)(a) and (c).
V A Whyte
Company Secretary
12 January 2012